grantGrants.gov

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

Organization National Institutes of HealthPosted 5 Dec 2024Deadline 7 Jan 2027
HHS-NIH1193.84093.23393.83993.83793.838synopsis
Sign up free to applyFree account · Full description · Apply link · All opportunity types

Full Description

Opportunity Number: PAR-25-026 Document Type: synopsis CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838

Read the full description

Sign up freeFree account · No credit card required
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) — National Institutes of Health | Dev Procure